SIGIDA crystal

Ophthalmology
Photo Product SIGIDA crystal Multidose 0.05% - Solopharm

Indications for use

Symptomatic temporary alleviation of secondary hyperaemia (redness) of eyes due to moderate irritation and allergic conjunctivitis.

Therapeutic class:

Decongestant - Alpha-adrenergic agonist

INN

Naphazoline

OSD bottle

Market authorization in the following countries

Uzbekistan

Back to catalog